This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Astra Zeneca U.k. Limited. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: The Innovations of Saravan Rajan
Introduction
Saravan Rajan is an accomplished inventor based in Wilmington, DE (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibodies targeting the spike protein of SARS-CoV-2. His work is crucial in the ongoing fight against COVID-19.
Latest Patents
Saravan Rajan holds a patent for "Antibodies That Bind the Spike Protein of SARS-CoV-2." This innovative patent is a testament to his expertise and dedication to advancing medical science. He has 1 patent to his name, showcasing his ability to contribute valuable solutions in the healthcare sector.
Career Highlights
Rajan is currently employed at AstraZeneca U.K. Limited, a leading global biopharmaceutical company. His role at AstraZeneca allows him to work on groundbreaking research and development projects that aim to improve patient outcomes and public health.
Collaborations
Throughout his career, Saravan has collaborated with notable colleagues, including Gilad Kaplan and Taylor Cohen. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of new therapies.
Conclusion
Saravan Rajan's contributions to biotechnology, particularly in the context of COVID-19, highlight his role as a key inventor in the field. His patent and work at AstraZeneca demonstrate his commitment to advancing medical science and improving global health.